Inventor
Jiuyang ZHAO
Inventor
CN
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds19%
A61KPreparations for medical, dental or toiletry purposes14%
Y02ATechnologies for adaptation to climate change14%
C07BGeneral methods of organic chemistry10%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium10%
C07CAcyclic or carbocyclic compounds5%
PatentTitleYear
11,453,672Substituted pyrazolo[1,5-a]pyrimidines as tropomyosin receptor kinase inhibitors202211,447,512Antiviral nucleoside reverse transcriptase inhibitor202211,389,463Antiviral nucleoside reverse transcriptase inhibitor202211,358,973Di(hetero)aryl macrocyclic compound for inhibiting protein kinase activity202211,345,703Substituted pyrazolo[1,5-a]pyrimidine macrocyclic compound202211,319,317(Hetero)arylamide compound for inhibiting protein kinase activity2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to SHENZHEN TARGETRX INC (6)· patent assignee history
2022Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SHENZHEN TARGETRX INC | 6 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 6 | 2022 |